Cardiac Alternans: From Bedside to Bench and Back

被引:16
|
作者
Qu, Zhilin [1 ]
Weiss, James N. [1 ]
机构
[1] UCLA, Dept Med, Div Cardiol, David Geffen Sch Med, A2-237 CHS,650 Charles E Young Dr South, Los Angeles, CA 90095 USA
基金
美国国家卫生研究院;
关键词
atrial fibrillation; Brugada syndrome; cardiovascular diseases; long QT syndrome; myocardial ischemia; torsades de pointes; ventricular fibrillation; T-WAVE ALTERNANS; ACTION-POTENTIAL DURATION; LONG-QT-SYNDROME; SPATIALLY DISCORDANT ALTERNANS; SARCOPLASMIC-RETICULUM CA2+; TORSADE-DE-POINTES; CONDUCTION-VELOCITY RESTITUTION; SODIUM-CHANNEL BLOCKER; RYANODINE RECEPTOR; REPOLARIZATION ALTERNANS;
D O I
10.1161/CIRCRESAHA.122.321668
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac alternans arises from dynamical instabilities in the electrical and calcium cycling systems of the heart, and often precedes ventricular arrhythmias and sudden cardiac death. In this review, we integrate clinical observations with theory and experiment to paint a holistic portrait of cardiac alternans: the underlying mechanisms, arrhythmic manifestations and electrocardiographic signatures. We first summarize the cellular and tissue mechanisms of alternans that have been demonstrated both theoretically and experimentally, including 3 voltage-driven and 2 calcium-driven alternans mechanisms. Based on experimental and simulation results, we describe their relevance to mechanisms of arrhythmogenesis under different disease conditions, and their link to electrocardiographic characteristics of alternans observed in patients. Our major conclusion is that alternans is not only a predictor, but also a causal mechanism of potentially lethal ventricular and atrial arrhythmias across the full spectrum of arrhythmia mechanisms that culminate in functional reentry, although less important for anatomic reentry and focal arrhythmias.
引用
收藏
页码:127 / 149
页数:23
相关论文
共 50 条
  • [41] From bedside to bench and back: Translating ASD models
    Drozd, Hayley P.
    Karathanasis, Sotirios F.
    Molosh, Andrei I.
    Lukkes, Jodi L.
    Clapp, D. Wade
    Shekhar, Anantha
    GENETIC MODELS AND MOLECULAR PATHWAYS UNDERLYING AUTISM SPECTRUM DISORDERS, 2018, 241 : 113 - 158
  • [42] Deciphering Hepatocellular Carcinoma: From Bench to Bedside and Back
    Goessling, Wolfram
    GASTROENTEROLOGY, 2009, 137 (03) : 786 - 788
  • [43] The drug development process - From the bench to bedside and back
    Tauscher, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S25 - S26
  • [44] Delving into PARP inhibition from bench to bedside and back
    Grignani, Giovanni
    Merlini, Alessandra
    Sangiolo, Dario
    D'Ambrosio, Lorenzo
    Pignochino, Ymera
    PHARMACOLOGY & THERAPEUTICS, 2020, 206
  • [45] Editorial: Pharmacogenomics: From Bench to Bedside and Back Again
    Shaman, Jeffrey A.
    Bousman, Chad A.
    Mitropoulou, Christina
    Padmanabhan, Sandosh
    FRONTIERS IN GENETICS, 2022, 13
  • [46] Health science: from bench to bedside to trench and back
    Lee, Simon J. Craddock
    NATURE, 2008, 454 (7202) : 274 - 274
  • [47] From bench to bedside and back again - emerging opportunities
    Bresnihan, Barry
    Buckley, Chris
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (05): : 827 - 828
  • [48] CDG and immune response: From bedside to bench and back
    Pascoal, Carlota
    Francisco, Rita
    Ferro, Tiago
    Ferreira, Vanessa dos Reis
    Jaeken, Jaak
    Videira, Paula A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (01) : 90 - 124
  • [49] Glutantinolysis and insulin secretion - From bedside to bench and back
    Kelly, A
    Li, CH
    Gao, ZY
    Stanley, CA
    Matschinsky, FM
    DIABETES, 2002, 51 : S421 - S426
  • [50] From bedside to the bench and back - Nitric oxide and the cutis
    Qureshi, AA
    Lerner, LH
    Lerner, EA
    ARCHIVES OF DERMATOLOGY, 1996, 132 (08) : 889 - 893